Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19.
COVID-19
long-COVID
persistent symptoms
post-COVID
prevalence
questionnaire
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
22
06
2021
accepted:
09
07
2021
pubmed:
14
7
2021
medline:
28
10
2021
entrez:
13
7
2021
Statut:
ppublish
Résumé
Post recovery manifestations have become another concern in patients who have recovered from coronavirus disease 2019 (COVID-19). Numerous reports have shown that COVID-19 has a variety of long-term effects on almost all systems including respiratory, cardiovascular, gastrointestinal, neurological, psychiatric, and dermatological systems. We aimed to investigate the prevalence and characteristics of the post-COVID syndrome among COVID-19 survivors and to determine the factors associated with persistent symptoms. This prospective study enrolled in patients with COVID-19 followed in hospital or outpatient clinics in Ankara City Hospital. We performed a special questionnaire to inquire about the presence of persistent symptoms beyond 12 weeks from the first diagnosis. Demographic data, comorbid diseases, characteristics of acute COVID-19, presence of persistent symptoms by systems, and knowledge about outpatient clinic visits after recovery were assessed. Of a total of 1007 participants, 39.0% had at least one comorbidity, and 47.5% had persistent symptoms. Fatigue/easy fatigability, myalgia, and loss of weight were the most frequent persistent symptoms (overall 29.3%) followed by respiratory symptoms (25.4%). A total of 235 participants had visited outpatient clinics due to several reasons during the post-COVID-19 period, and 17 of them were hospitalized. Severe acute COVID-19, hospitalization, and presence of comorbidity were independent factors for the development of persistent symptoms. Fully understanding the spectrum of the post-COVID syndrome is essential for appropriate management of all its long-term effects. Our study once again underlined the fact that the prevalence of post-COVID syndrome is higher than expected and concerns many systems, and a multidisciplinary follow-up should be provided to COVID-19 survivors in the post recovery period.
Identifiants
pubmed: 34255355
doi: 10.1002/jmv.27198
pmc: PMC8426910
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6566-6574Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Diabetes Metab Syndr. 2021 May-Jun;15(3):869-875
pubmed: 33892403
BMJ. 2020 Aug 11;370:m3026
pubmed: 32784198
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
J Med Virol. 2021 Dec;93(12):6566-6574
pubmed: 34255355
BMJ. 2021 Mar 31;372:n693
pubmed: 33789877
Lancet Psychiatry. 2021 Feb;8(2):130-140
pubmed: 33181098
Brain Behav Immun. 2020 Oct;89:594-600
pubmed: 32738287
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
Int J Clin Pract. 2021 Mar;75(3):e13746
pubmed: 32991035
Open Forum Infect Dis. 2021 Jan 29;8(4):ofab042
pubmed: 33875970
J Med Virol. 2021 May;93(5):2555-2556
pubmed: 33095459
J Infect. 2021 Mar;82(3):378-383
pubmed: 33450302
Int J Environ Res Public Health. 2021 Mar 05;18(5):
pubmed: 33807869
Clin Microbiol Infect. 2021 Feb;27(2):258-263
pubmed: 33031948
BMC Infect Dis. 2021 Mar 25;21(1):304
pubmed: 33765941
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
BMJ. 2020 Dec 23;371:m4938
pubmed: 33361141
Psychiatry Res. 2021 Jan;295:113599
pubmed: 33285346
JAMA. 2020 Dec 8;324(22):2251-2252
pubmed: 33206133
PLoS One. 2021 Apr 8;16(4):e0249644
pubmed: 33831043
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238